ATC code N

Pharmaceutical drug classification
ATC code N: Nervous system
  • N01 Anesthetics
  • N02 Analgesics
  • N03 Antiepileptics
  • N04 Anti-parkinson drugs
  • N05 Psycholeptics
  • N06 Psychoanaleptics
  • N07 Other nervous system drugs
ATCvet only
  • QN51 Products for animal euthanasia
Other ATC codes

ATC code N Nervous system is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3][4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QN.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

References

  1. ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. ^ "ATC/DDD Index 2022: code N". WHO Collaborating Centre for Drug Statistics Methodology.
  5. ^ "ATCvet Index 2022: code QN". WHO Collaborating Centre for Drug Statistics Methodology.
  • v
  • t
  • e
Major chemical drug groups – based upon the Anatomical Therapeutic Chemical Classification System
gastrointestinal tract
/ metabolism (A)blood and blood
forming organs (B)cardiovascular
system (C)skin (D)genitourinary
system (G)endocrine
system (H)infections and
infestations (J, P, QI)malignant disease
(L01–L02)immune disease
(L03–L04)muscles, bones,
and joints (M)brain and
nervous system (N)respiratory
system (R)sensory organs (S)other ATC (V)
  •  Drugs
  • Pharmacological classification systems
  • ATC codes
  •  Medicine portal
  • v
  • t
  • e
Inhalational
Injection
Phenols
Barbiturates
Benzodiazepines
Opioids
Arylcyclohexylamines
Neuroactive steroids
Others
  • v
  • t
  • e
Esters by acid
Aminobenzoic
Benzoic
ArCO2- (not para-amino or Ph)
  • Amoproxan (3,4,5-Trimethoxybenzoyl)
  • 3-(p-Fluorobenzoyloxy)tropane
Amides
Combinations
  • v
  • t
  • e
Opioids
Opiates/opium
Semisynthetic
Synthetic
Paracetamol-type
NSAIDs
Propionates
Oxicams
Acetates
COX-2 inhibitors
Fenamates
Salicylates
Pyrazolones
Others
Cannabinoids
Ion channel
modulators
Calcium blockers
Sodium blockers
Potassium openers
Myorelaxants
Others
  • v
  • t
  • e
Antimigraine preparations (N02C)
Analgesic/abortive
Serotonergics
Ergolines
5-HT1 agonists
Triptans
Ditans
Others
CGRP-R antagonists
Others
Prophylactic
Calcium channel blockers
Progestogens
Sympatholytics
Tricyclic antidepressants
Anticonvulsants
Anti-CGRP/CGRP-R mAbs
CGRP-R antagonists
  • v
  • t
  • e
GABAergics
GABAAR PAMs
GABA-T inhibitors
Others
Channel
modulators
Sodium blockers
Calcium blockers
Potassium openers
Others
CA inhibitors
Others
  • v
  • t
  • e
Dopaminergics
DA precursors
DA receptor agonists
MAO-B inhibitors
COMT inhibitors
AAAD inhibitors
Anticholinergics
Others
  • v
  • t
  • e
D1-like
Agonists
PAMs
Antagonists
D2-like
Agonists
Antagonists
  • See also: Receptor/signaling modulators
  • Adrenergics
  • Serotonergics
  • Monoamine reuptake inhibitors
  • Monoamine releasing agents
  • Monoamine metabolism modulators
  • Monoamine neurotoxins
  • v
  • t
  • e
Typical
Disputed
Atypical
Others
  • v
  • t
  • e
5-HT1ARTooltip 5-HT1A receptor agonists
GABAARTooltip GABAA receptor PAMsTooltip positive allosteric modulators
Hypnotics
Gabapentinoids
(α2δ VDCC blockers)
Antidepressants
Antipsychotics
Sympatholytics
(Antiadrenergics)
Others
  • v
  • t
  • e
GABAA
Alcohols
Barbiturates
Benzodiazepines
Carbamates
Imidazoles
Monoureides
Neuroactive steroids
Nonbenzodiazepines
Phenols
Piperidinediones
Quinazolinones
Others
GABAB
H1
Antihistamines
Antidepressants
Antipsychotics
α2-Adrenergic
5-HT2A
Antidepressants
Antipsychotics
Others
Melatonin
Orexin
α2δ VDCC
Others
  • v
  • t
  • e
SSRIsTooltip Selective serotonin reuptake inhibitors
SNRIsTooltip Serotonin–norepinephrine reuptake inhibitors
NRIsTooltip Norepinephrine reuptake inhibitors
NDRIsTooltip Norepinephrine–dopamine reuptake inhibitors
NaSSAsTooltip Noradrenergic and specific serotonergic antidepressants
SARIsTooltip Serotonin antagonist and reuptake inhibitors
SMSTooltip Serotonin modulator and stimulators
Others
TCAsTooltip Tricyclic antidepressants
TeCAsTooltip Tetracyclic antidepressants
Others
Non-selective
MAOATooltip Monoamine oxidase A-selective
MAOBTooltip Monoamine oxidase B-selective
Miscellaneous
  • v
  • t
  • e
Psychostimulants, agents used for ADHD, and nootropics (N06B)
N06BA
Centrally acting sympathomimetics
N06BC
Xanthine derivatives
N06BX
Other psychostimulants and nootropics
  • v
  • t
  • e
Index of psychology and psychiatry
Description
  • Mental processes
Disorders
  • Mental and behavioral
    • ADHD
    • OCD
    • Tourette's
  • Mood
  • Developmental
    • pervasive
    • dyslexia and specific
  • Substance-related
    • alcohol
  • Emotional and behavioral disorders
  • Symptoms and signs
  • Evaluation and testing
Treatment
  • Psychotherapy
    • CBT
  • Drugs
    • depression
    • antipsychotics
    • anxiety
    • dementia
    • hypnotics and sedatives
  • v
  • t
  • e
mAChRsTooltip Muscarinic acetylcholine receptors
Agonists
Antagonists
Precursors
(and prodrugs)
See also
Receptor/signaling modulators
Nicotinic acetylcholine receptor modulators
Acetylcholine metabolism/transport modulators
  • v
  • t
  • e
nAChRsTooltip Nicotinic acetylcholine receptors
Agonists
(and PAMsTooltip positive allosteric modulators)
Antagonists
(and NAMsTooltip negative allosteric modulators)
Precursors
(and prodrugs)
See also
Receptor/signaling modulators
Muscarinic acetylcholine receptor modulators
Acetylcholine metabolism/transport modulators